This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Located in kp’s Villa Del Totoral, Argentina, facility, the state-of-the art laminating line expands the company’s existing capacity for high-quality Pentapharm® ACLAR® PVC/PCTFE films, as well as high- barrier Pentafood® films. The $3.3 million USD investment will provide shorter lead times for kp’s customers in the region and locally supply material structures that were previously available only on an import basis from kp facilities in the US and Europe. All Pentapharm® pharmaceutical films are registered in the FDA Global Drug Master File #3764.
“For more than 20 years, we have been committed to supporting our South American customers with consistent, high-quality film and superior service and technical support,” says Michael Tubridy, President & COO, Klöckner Pentaplast/Americas. “The most recent investment in pharmaceutical barrier film capacity further demonstrates our commitment to the Argentine and South American markets. By providing additional capacity and new material structures, we are positioned to support our customers’ growth and explore new film solutions for meeting their packaging needs.”
